1. Postigo JAR (2010) Leishmaniasis in the World Health Organization. Eastren Meditrenean Region. Int J Antimicrobial Agents 369(Suppl 1):S62-5
2. Ali A. Development of affordable molecular techniques for the diagnosis of leishmaniasis in Yemen. Biochemishes institute, der Medizinischem Fakultait, der Justus –Liebig- Universitait Giessen ,http//geb.uni-giessen. Del/geb/volltexte/2011/8060/pdf/Ali Abdulatif_2011_03_22_pdf.{Accessed December 10.2023}
3. Schetter AJ, Hwgaard NH, Harris CC (2010) Inflammation and cancer; interweaving microRNA; free radical, cytokine and p53 pathways. Carcinogenesis 31(1):37–49
4. Vera-lazaguirre D, Vega-Memije E, Quintanilla M et al (2008) Leishmaniasis revision. DCMQ 4(4):252–260
5. Rioux JA, Daoud W, Pratlong F, et al. (1986) Les complexes Leishmania donovani s. st. Leishmania tropica et Leishmania major en Republique Arabe du Yemen. In: Rious JA, ed. Leishmania: Taxonomi –PhylogeneseApplications, Eco-Epidemiologiques. Montpellier: Institut Mediterraneen dEtudes Epidemiologiques et Ecologiques,: 357-363.